Company Update Cipla Ltd - 500087 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure … BSE India Company has received final approval from USFDA for ANDA submitted for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound), 100 mg/vial, Single-Dose Vial (''Protein-bound Paclitaxel'') on 10th April, 2025